Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer

Overview of attention for article published in Frontiers in immunology, July 2022

Altmetric Badge

Mentioned by

twitter: 4 X users

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 3,972 followers.

CAFDL risk stratification and provide new insights into the underlying mechanisms of CAFs in cancer immunity. https://t.co/cyGYQoZXuV https://t.co/2D44rqLyN1

27 Aug 2022

Reply Repost Favourite

Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer https://t.co/PgE3MUBUmf https://t.co/Xgi30pSG4M

16 Aug 2022

Reply Repost Favourite

New article: Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer https://t.co/TiTmVeaVHD #gastriccancer #oncology https://t.co/2ppnE0WmMC

15 Aug 2022

Reply Repost Favourite

Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer https://t.co/dl3JV4CT70

15 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.